Сравнительный анализ экспрессии генов в атеросклеротических поражениях аорты человека и в лейкоцитах периферической крови больных эссенциальной гипертензией
Диссертация
Для количественной оценки исследуемых кДНК использовали серийно разведенный внешний стандарт. Диапазон концентраций внешнего стандарта по величине был сопоставим с определяемой концентрацией анализируемой кДНК и подбирался в предварительном эксперименте по одинаковому выходу продуктов ГТЦР, полученных на кДНК и внешнем стандарте. По 1 мкл образца кДНК и серийно разведенного внешнего стандарта… Читать ещё >
Список литературы
- Андреева ЕР, Михайлова ИА, Пугач ИМ, Орехов АН. Клеточный состав атеросклеротических поражений аорты человека // Ангиология и сосудистая хирургия. 1999, № 5. — С. 6−26.
- Анестиади В., Нагорнев В. Морфогенез атеросклероза. Кишинев, 1982.- 159−160с, 238−240с.
- Гусев ЕИ, Скворцова ВИ, Мартынов МЮ, Камчатнов ПР. Церебральный инсульт: проблемы и решения // Вестник РГМУ. 2006, № 4. — С.28−32
- Давыдовский ИВ. Атеросклероз как проблема возраста. Геронтология. -М., 1966. 204−219с.
- Жданов B.C., A.M. Вихерт, Н. Г. Стернби. Эволюция и патология атеросклероза у человека. М., 2002
- Зайко НН,. Ю. В. Быць, А. В. Атаман и др. /Патологическая физиология- Учебник/ К.: «Логос», 1996.
- Климов АН., Синицына Т. А., Нагорнев В. А. Развитие идей НН Аничкова на современном этапе учения об атеросклерозе // Арх пат. -1975. -№ 11.-С. 3−16.
- Ланкин ВЗ., Гуревич СН. Системы, ответственные за перекисное окисление полиеновых жирных кислот при экстремальном злокачественном росте. Липиды в организме животных и человека. -Под ред. СЕ Северина. М., — 1974. — 72−77с.
- Маниатис Т., Методы генетической инженерии. Молекулярное клонирование, 1984, — 197−199с.
- Оранов РГ. Профилактическая кардиология: от гипотез к практике. // Кардиология. 1999. — № 39. — С. 4−9.
- Соболева ЭЛ., Попкова ВМ. Гемопоэтические клетки-предшественники в интиме атероматозной аорты человека. // Бюлл. Эксп. Биол. Мед. 1986. — № 5. — С. 600−604.
- Струков АИ, Серов ВВ, Патологическая анатомия. 1993, издание третье, — С. 277−284.
- Чазов Е.И. Болезни сердца и сосудов. 1992, — Т. 2, С. 136−177.
- Шевченко Ю, Щепин О, Смертность населения РФ в 1999 г. // Мед. Курьер.-2001,-С. 1−2.
- Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques // Circ Res. 2000. — V. 86. — P. 131−8.
- Agranovsky, A.A. Exogenous primer-independent cDNA synthesis with commercial reverse transcriptase preparations on plant virus RNA templates //Anal. Biochem. 1992.-Vol. 203.-P. 163−165.
- Akgul C, Edwards SW. Regulation of neutrophil apoptosis via death receptors // Cell Mol Life Sci. 2003. — Vol. 60. — P. 2402−8.
- Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective // Hypertension. 1995. — Vol. 25.-P. 155−161.
- Allali-Hassani A, Martinez SE, Peralba JM, Vaglenova J, Vidal F, Richart C, Farres J, Pares X. Alcohol dehydrogenase of human and rat blood vessels. Role in ethanol metabolism // FEBS Lett. 1997. — Vol. 405. -P.26−30.
- Anger T, El-Chafchak J, Habib A, Stumpf C, Weyand M, Daniel WG, Hombach V, Hoeher M, Garlichs CD. Statins stimulate RGS-regulated ERK ½ activation in human calcified and stenotic aortic valves // Exp Mol Pathol.-2008.-Vol. 85.-P. 101−11.
- Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A, Bookout AL, Male PA, Edwards PA, Mangelsdorf DJ, Tontonoz P, Miyazaki T. A role for the apoptosis inhibitory factor AIM/Sp/Api6 in atherosclerosis development //
- Cell Metabolism. 2005. — Vol. 1. — P.201−213.
- Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity // Science. -2000. Vol. 287. — P. 860−864.
- Ashkenazi A, Dixit V. Death receptors: signaling and modulation // Science. 1998.-Vol. 281.-P. 305−8
- Aslanian AM, Chapman HA, and Charo IF. Transient role for CD Id-restricted natural killer T cells in the formation of atherosclerotic lesions // Arterioscler Thromb Vase Biol. 2005. — Vol. 25. — P. 628−632.
- Baird A, Durkin T. Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors // Biochem Biophys Res Commun. 1986. — Vol. 138. — P. 476−82.
- Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, Boned A, Sieweke MH. Balance of MafB and PU. l specifies alternative macrophage or dendritic cell fate // Blood. 2005. — Vol. 105. — P. 2707−16.
- Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration // J Clin Invest. -2001.-Vol. 108.-P. 1759−1770 .
- Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis // Arterioscler Thromb Vase Biol. 2002. -Vol. 22.-P. 717−26.
- Barshevskaia, T.N., Goriunova, L.E., Bibilashvili, R.S. Non-specific RNA degradation in the presence of divalent magnesium ions // Mol. Biol. 1987. -Vol. 21.-P. 1235−1241.
- Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro // Arterioscler Thromb. 1991. — Vol. 11.-P. 254−60.
- Baumgarth N, Tung JW, and Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion // Springer Semin Immunopathol. 2005. — Vol. 26. — P. 347−362.
- Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis // Circ Res. 2000. — Vol. 86.-P. 125−30.
- Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, and Brenner MB. Recognition of a lipid antigen by CD 1-restricted alpha beta+ T cells // Nature. 1994.-Vol. 372.-P. 691−694.
- Benditt EP and Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaque // Proc Natl Acad Sci. 1973. — Vol.70. — P. 17 531 756.
- Bernstein, L.B., S.M. Mount and A.M. Weiner. Pseudogenes for human small nuclear RNA U3 appear to arise by integration of self-primed reverse transcripts of the RNA into new chromosomal sites // Cell. 1983. — Vol. 32.-P. 461−472.
- Bevan RD. Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery // Circ Res. 1975. — Vol. 37. -P. 14−9.
- Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion // Am J Pathol. 1985. — Vol. 121. — P. 394−403.
- Biesiada E, Razandi M, Levin ER. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation // J Biol Chem.- 1996.-Vol. 271.-P. 18 576−81.
- Bingley JA, Hay ward IP, Campbell JH, Campbell GR. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo // J Vase Surg. -1998.-Vol. 28.-P. 308−18.
- Bobik A, Grinpulcel S, Little PJ. et al. Angiotensin II and noradrenaline increase PDGF BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle // Biochem Biophys Res Commun. -1990.-Vol. 166.-P. 580−8.
- Bobryshev YV and Lord RS. Co-accumulation of dendritic cells and natural killer T cells within ruptureprone regions in human atherosclerotic plaques // J Histochem Cytochem. 2005a. — Vol. 53. — P. 781−785.
- Bobryshev YV and Lord RS. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis // J Vase Surg. 2002. — Vol. 35. — P. 368−375.
- Bobryshev YV and Lord RS. Identification of natural killer cells in human atherosclerotic plaque // Atherosclerosis. 2005b. — Vol. 180. — P. 423−427.
- Bobryshev YV and Lord RS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions // Cardiovasc Res. 1998. — Vol. 37. — P. 799−810.
- Bobryshev YV and Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions // Cardiovasc Res. 1995. — Vol.29. — P. 689 696.
- Bobryshev, Y.V., Cherian, S.M., Inder, S.J., Lord, R.S.A., Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation // Cardiovasc Res. 1999. — Vol. 43. — P. 10 031 017
- Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice // J Clin Invest. 1998.-Vol. 101.-P. 353−63.
- Boldt K, Rist W, Weiss SM, Weith A, Lenter MC. FPRL-1 induces modifications of migration-associated proteins in human neutrophils // Proteomics. 2006. — Vol. 6. — P. 4790−4799.
- Boman J and Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies // Clin Microbiol Rev. 2002. — Vol. 15. — P. 1−20.
- Bonthron DT, Morton CC, Orkin SH, Collins T. Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing // Proc Natl Acad Sci USA.- 1988. Vol. 85. -P. 1492−6.
- Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members // J Biol Chem.- 1998.-Vol. 273.-P. 28 040−8.
- Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa В is present in the atherosclerotic lesion // J Clin Invest. 1996. — Vol. 97. — P. 1715−22.
- Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, and Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice // Arterioscler Thromb Vase Biol. 2004. -Vol. 24.-P. 2137−2142.
- Brooks, E.M., L.G. Sheflin and S.W. Spaulding. Secondary structure in the. 3'UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR // BioTechniques. 1995. — Vol. 19. — P. 806−815.
- Brown MS, Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system // Proc Natl Acad Sci USA.- 1979. Vol. 76. -P. 3330−7. ~ -
- Broxmeyer FIE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist // J Exp Med. 2005. -Vol. 201.-P. 1307−18.
- Burke-Gaffney A, Brooks AV, Bogle RG. Regulation of chemokine expression in atherosclerosis // Vascul Pharmacol. 2002. — Vol. 38. — P. 283−92.
- Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress // Circ Res. 2000. — Vol. 87. — P. 840−4.
- Caligiuri G, Nicoletti A, Poirier B, and Hansson GK. Protective immunity against atherosclerosis carried by В cells of hypercholesterolemic mice // J Clin Invest. 2002. — Vol. 109. — P. 745−753.
- Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, and Nicoletti A. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice // Mol Med. -2003.-Vol. 9.-P. 10−17.
- Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo В lipoproteins with arterial proteoglycans: pathological significance and molecular basis // Atherosclerosis. 1998. — Vol. 139. — P. 205−22.
- Cannon RO. Role of nitric oxide in cardiovascular disease: focus on the endothelium // Clin Chem. 1998. — Vol. 44. — P. 1809−1819.
- Cattaruzza M, Dimigen C, Ehrenreich H, Hecker M. Stretch-induced endothelin В receptor-mediated apoptosis in vascular smooth muscle cells // FASEB J. 2000. — Vol. 14. — P. 991−998.
- Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression // Nat Med. 2001. -Vol. 7.-P. 425—429.
- Chang L, Karin M. Mammalian MAP kinase signalling cascades // Nature. -2001.-Vol. 410.-P. 37−40.
- Chang MK, Binder С J, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, and Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory // J Exp Med. 2004. -Vol. 200.-P. 1359−1370.
- Chen JK, Hoshi H, McKeehan WL. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells // Proc Natl Acad Sci USA.- 1987. Vol. 84. — P. 5287−91.
- Chesler NC, Ku DN, Galis ZS. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo // Am J Physiol. 1999. -Vol. 277. — P. H2002−9.
- Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation // Inflamm Res. 2000. — Vol. 49. — P. 497 505.
- Chon H, Gaillard CA, van der Meijden BB, Dijstelbloem HM, Kraaijenhagen RJ, et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment // Hypertension. 2004. — Vol. 43. — P. 947−51.
- Chong KY, Lai CC, Lille S, Chang C, Su CY. Stable overexpression of the constitutive form of heat shock protein 70 confers oxidative protection // J Mol Cell Cardiol. 1998. — Vol. 30. — P. 599−608.
- Chu РН, Ruiz-Lozano P, Zhou Q, Cai C, and Chen J. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system // Mech Dev. 2000. — Vol. 95. — P. 259−265.
- Claesson-Welsh L. Mechanism of action of platelet-derived growth factor // Int L Biochem Cell Biol. 1996. — Vol. 28. — P. 373−385.
- Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors // Biochem Soc Trans. 2003. — Vol. 31. — P. 20−24.
- Clerc G and Rouz PM. Lymphocyte subsets in severe atherosclerosis before revascularization//Ann Intern Med. 1997.-Vol. 126.-P. 1004−1005.
- Clowes AW, KarnowskyMJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries // Nature. 1977. — Vol. 265. — P. 625−6.
- Cohen GM. Caspases: the executioners of apoptosis // Biochem J. 1997. -Vol. 326.-P. 1−16.
- Collins T. and Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? // J Clin Invest. 2001. — Vol. 107. — P. 255 264.
- Cottrez F and Groux H. Specialization in tolerance: innate CD (4+)CD (25+) versus acquired TR1 and TH3 regulatory T cells // Transplantation. 2004. -Vol. 77. — P. S12-S15.
- Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, and Gaston JS. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens // Clin Exp Immunol. 2000. — Vol. 121. -P. 261−269. — -
- Dao, H.H., F.M. Martens, R. Lariviere, N. Yamaguchi, P. Cernacek, J. Champlain, and P. Moreau. Transient involvement of endothelin in hypertrophic remodeling of small arteries // J Hypertens. 2001. — Vol. 19. -P. 1801−1812.
- Daugherty A, Webb NR, Rateri DL, and King VL. Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis // J Lipid Res. 2005. — Vol. 46. — P. 1812−1822.
- Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content // Br Heart J. 1993. — Vol. 69. — P. 377−81.
- Derynck R, Rhee L, Chen EY, Van Tilburg A. Intron-exon structure of the human transforming growth factor-beta precursor gene // Nucleic Acids Res. 1987.-Vol. 15. — P. 3188−9.
- Diep QN, Li JS, Schiffrin EL. In vivo study of ATI and AT2 angiotensin receptors in apoptosis of rat blood vessels // Hypertension. 1999. — Vol. 34.-P. 617−624.
- Diguid J. Trombosis as a factor in the pathogenesis of coronary atherosclerosis // J Pathol Bacterid. 1946. — Vol. 58. — P. 207−212.
- Dinarello CA. Interleukin-1 // Cytokine Growth Factor Rev. 1997. — Vol. 8.-P. 253−265.
- Doevendans PA, Jukema W, Spiering W, Defesche JC, Kastelein JJ. Molecular genetics and gene expression in atherosclerosis // Int J Cardiol.2001.-Vol. 80.-P. 161−72.
- Dorffel Y, Latsch C, Stuhlmuller-B, et al. Preactivated peripheral blood monocytes in patients with essential hypertension // Hypertension. 1999. -Vol. 34.-P. 113−7.
- Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1) // J Immunol. 1986. — Vol. 137.-P. 245−54.
- Edfeldt K, Swedenborg J, Hansson GK, and Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation//Circulation. 2002.-Vol. 105.-P. 1158−1161.
- Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns // Proc Natl Acad Sci US A.-1998. Vol. 95. — P. 14 863−14 868.
- Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, and Hansson GK. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice // Cardiovasc Res. 2003. — Vol. 59. — P. 234−240.
- Enari M, Sakahira H et al. A caspase-activated Dnase that degrades DNA during apoptosis and its inhibitor ICAD // Nature. 1998. — Vol. 391. — P. 43−50.
- Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein // J Biol Chem. -1993.-Vol. 268.-P. 11 811−6.
- Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors // Nat Med. 2003. — Vol. 9. — P. 669−76.
- Fiebeler A. and F.C.Luft. The mineralcorticoid receptor and oxidative stress
- Heart Failure Reviews. 2005. — Vol. 10. — P. 47−52.
- Folkman J. and Shing Y. Angiogenesis. // J Biol Chem. 1992. — Vol. 267.-P. 10 931−10 934.
- Fox JC, Shanley JR. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells // J Biol Chem. 1996. -271.-P. 12 578−84.
- Frenette PS, Wagner DD. Adhesion molecules-Part 1 // N Engl J Med. -1996.-Vol. 334.-P. 1526−9.
- Frostegard J, Kjellman B, Gidlund M, Andersson B, Jindal S, and Kiessling R. Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein // Atherosclerosis. 1996. — Vol. 121. — P. 93−103.
- Gabig TG, Mantel PL, Rosli R, Crean CD. Requiem: a novel zinc finger gene essential for apoptosis in myeloid cells // J Biol Chem. 1994. — Vol. 269.-P. 29 515−29 519.
- Galis ZS, Sukhova GK, Lark MW, and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques // J Clin Invest. 1994b. — Vol. 94. -P. 2493−2503.
- Gargalovic P, Dory L. Caveolins and macrophage lipid metabolism // J Lipid Res. -2003.- Vol. 44.-P. 11−21.
- Geisterfer AT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, in cultured rat aortic smooth muscle cells // Circ Res. -1988.-Vol. 62.-P. 749−56.
- George J, Afek A, Gilburd B, Blank M, Levy Y, ron-Maor A, Levkovitz H, et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I // Circulation. 1998. — Vol. 98. — P. 1108−1115.
- George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic J, Wick G, and Harats D. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65 // Arterioscler Thromb Vase
- Biol. 1999b. — Vol. 19. — P. 505−510.
- George SJ. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis // Curr Opin Lipidol. 1998. — Vol. 9. — P. 413−23.
- Gerard G. F. Making effective use of cloned M-MLV reverse transcriptase // Focus. 1987. — Vol. 9. — P. 5−6.
- Gerszten RE, Mach F, Sauty A, Rosenzweig A, Luster AD. Chemokines, leukocytes, and atherosclerosis // J Lab Clin Med. 2000. — Vol. 136. — P. 87−92.
- Ghosh S, St Clair RW, Rudel LL. Mobilization of cytoplasmic CE droplets by overexpression of human macrophage cholesteryl ester hydrolase // J Lipid Res. 2003. — Vol. 44. — P. 1833−40.
- Girard JP, Springer ТА. High endothelial venules (PIEVs): specialized endothelium for lymphocyte migration // Immunol Today. 1995. — 16. — P. 449−57.
- Girard JP, Springer TA. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules // J Biol Chem. -1996.-Vol. 271.-P. 4511−7.
- Goldstein JL., Brown MS. Lipoproteins receptors, cholesterol metabolism and atherosclerosis // Arch Pathol. 1975. — Vol. 99. — P. 181−184.
- Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries // Proc Natl Acad Sci USA.- 1990. Vol. 87. -P. 4600−4.
- Grainger DJ, Reckless J, McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice // J Immunol. -2004. Vol. 173. — P. 6366−6375.
- Greaves DR and Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors // J Lipid Res. 2005. — Vol. 46. — P. 11−20.
- Gregory CD, Devitt A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? // Immunology. 2004. -Vol. 113.-P. 1−14.
- Grimsley C, Ravichandran KS. Cues for apoptotic cell engulfment: eat-me, don’t eat-me and come-get-me signals // Trends Cell Biol. 2003. -Vol. 13. -P. 648−56.
- Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM. Differential regulation of the MAP, SAP and RK/p38 kinases by Pystl, a novel cytosolic dual-specificity phosphatase // EMBO J. 1996. — Vol. 15. — P. 3621−32.
- Gutterman, D.D. Adventitia-dependent influences on vascular function. // Am. J. Physiol. 1999. — Vol. 277. — P. H1265-H1272.
- Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis // Arterioscler Thromb Vase Biol. 1996. — Vol. 16. — P. 411.
- Hahn, A.W., U. Jonas, F.R. Buhler, and T.J. Resink. Activation of human peripheral monocytes by angiotensin II // FEBS Lett. 1994. — Vol. 347. -P. 178−180.
- Hamet P, deBlois D, Dam TV, Richard L, Teiger E, Tea BS, Orlov SN, Tremblay J. Apoptosis and vascular wall remodeling in hypertension // Can J Physiol Pharmacol. 1996. — Vol. 74. — P. 850−861
- Han KH, Hong КН, Ко J, Rhee KS, Hong MK, Kim JJ, Kim YH, Park SJ. Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells // J Leukoc Biol. 2004. — Vol. 76(1). -P. 195−202.
- Hansson GK, Holm J, and Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque // Am J Pathol. 1989. -Vol. 135.-P. 169−175.
- Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis // Arteriosclerosis. 1989. — Vol. 9. — P. 567−78.
- Hansson GK. Immune Mechanisms in Atherosclerosis // Arterioscler Thromb Vase Biol. 2001. — Vol. 21. — P. 1876−1890.
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease // N Engl J Med. 2005. — Vol. 352. — P. 1685−1695.
- Hara Y, Kusumi Y, Mitsumata M, Li XK, Fujino M. Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat // J Thromb Thrombolysis. 2008. — Vol. 26. — P. 113−8.
- Harada M, Habata Y, Hosoya M, Nishi K, Fujii R, Kobayashi M, et al. N-formylated humanin activates both formyl peptide receptor-Like 1 and 2 // Biochem Biophys Res Commun. 2004. — Vol. 324. — P. 255−61.
- Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis // Am J Cardiol. 2003. — Vol. 91. — P. 7 A-11 A.
- Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocytes and macrophages // Blood. 1999. — Vol. 94. — P. 837−44.
- Hatzoglou A, Ader I, Splingard A, Flanders J, Saade E, Leroy I, Travel" S, Aresta S, de Gunzburg J. Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway // Mol Biol Cell. -2007.-Vol. 18.-P. 1242−52.
- Hayashi K, Madri JA, Yurchenco PD. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan // J Cell Biol. -1992.-Vol. 119.-P. 945−59.
- Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, et al. Human vascular smooth muscle cells express receptors for CC chemokines // Arterioscler Thromb Vase Biol. 1998. — Vol. 18. — P. 397−403
- Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor // Physiol Rev. 1999. — Vol. 79. — P. 1283−316.
- Heldin CH. Structural and functional studies on platelet-derived growth factor // EMBO J. 1992. — Vol. 11. — P. 4251 -9.
- Henis-Korenblit S, Strumpf NL, Goldstaub D, Kimchi A. A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation // Mol Cell Biol. -2000. Vol. 20. — P. 496−506.
- Hiltunen MO, Tuomisto TT, Niemi M, Brasen JH, Rissanen TT, Toronen P, Vajanto I, Yla-Herttuala S. Changes in gene expression in atherosclerotic plaques analyzed using DNA array // Atherosclerosis. 2002. — Vol. 165. -P. 23−32.
- Hinek A., Rosnowsky A. Comparison of morphology of isolated cells obtained from aortas of normal and cholesterol fed rabbits // Arterial Wall. -1975.-Vol. 3. P. 17−29.
- Hochberg Z, Hertz P, Maor G, Oiknine J, Aviram M. Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein // Endocrinology. 1992.-Vol. 131.-P. 430−5.
- Hofmann, M.A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, et al. RAGE mediates a novel proinflammatoryaxis: a central cell surface receptor for S100/calgranulin polypeptides // Cell. 1999. — Vol. 97. — P. 889−901.
- Holmgren A. Thioredoxin and glutaredoxin systems // J Biol Chem. 1989. -Vol. 264.-P. 13 963−13 966.
- Horkko S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W, Witztum JL. Immunological responses to oxidized LDL // Free Radic Biol Med. 2000. — Vol. 28.-P. 1771−1779.
- Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. ReguIated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation // Blood. 1996. — Vol. 87. -P. 2020−8.
- Ibrahim Al, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts // J Clin Virol. 2005. — Vol. 32. — P. 29−32.
- Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily // Trends Genet. 1995. — Vol. 11. — P. 69−74.
- Ikeda M, Kohno M, Yasunari К, Yokokawa К, Horio T, Ueda M, Morisaki N, Yoshikawa J. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells // Arterioscler Thromb Vase Biol. 1997. -Vol. 17.-P. 731−6.
- Imataka, H., H. S. Olsen, and N. Sonenberg. A new translational regulator with homology to eukaryotic translation initiation factor 4G // EMBO J. -1997.-Vol. 16.-P. 817−825
- Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants // Hypertension. 2000. — Vol. 36. — P. 312−8.
- Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis // Hypertension. 2001. — Vol. 38. -P. 581−7
- Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling // Circ Res. 2000. -Vol. 87.-P. 179−183
- Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data // Nucleic Acids Res. -2003,-Vol. 31.-P. el5.
- Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication // Hypertension. 1992. — Vol. 20. — P. 713−36
- Janicke RU, Sprengart ML et al. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis // J Biol Chem. 1998. — Vol. 273. — P. 9357−60
- Jonasson L, Holm J, Skalli O, Bondjers G, and Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque // Arteriosclerosis. 1986. — Vol. 6. — P. 131 138.
- Kaartinen M, Penttila A, and Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture // Circulation. 1994. — Vol. 90. — P. 16 691 678.
- Kaartinen M, Penttila A, and Kovanen PT. Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage // Atherosclerosis. 1996. — Vol. 123. — P. 123−131.
- Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE, and Kovanen PT. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture // J Am Coll Cardiol. 1998. — Vol. 32. — P. 606−612.
- Kintscher U. et al. Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes // Hypertension. 2001. — Vol. 37. -P. 587−593
- Kishino J et al. Endothelin-induced intracellular Ca2+ mobilization through its specific receptors in murine peritoneal macrophages // FEBS Lett. -1991. Vol. 280.-P. 103−106
- Kobayashi K, Kishi M, Atsumi T, Bertolaccini ML, Makino H, Sakairi N, et al. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen // J Lipid Res. 2003. — Vol. 44. -P. 716−726.
- Kockx MM, De Meyer GR, Buyssens N, Knaapen MW, Bult H, Herman AG. Cell composition, replication, and apoptosis in atherosclerotic plaquesafter 6 months of cholesterol withdrawal // Circ Res. 1998. — Vol. 83. — P. 378−387.
- Kodali R, Hajjou M, Berman AB, Bansal MB, Zhang S, Pan JJ, Schecter AD. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells // Cardiovasc Res. 2006. — Vol. 69. — P. 706−15
- Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils // Nature. 1990.-Vol. 343.-P. 531−5.
- Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma // N Engl J Med. -2003.-Vol. 349.-P. 2316−2325.
- Kovanen PT, Kaartinen M, and Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction// Circulation. 1995. — Vol. 92. — P. 1084−1088.
- Kovanen PT, Pentikainen MO. Secretory group II phospholipase A (2): a newly recognized acute-phase reactant with a role in atherogenesis // Circ Res.-2000.-86.-P. 610−2.
- Kovanen PT. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation // Curr Opin Lipidol. 1996. — Vol. 7. — P. 281−6.
- Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells // Immunol Lett. 1995. — Vol. 45. — P. 61−5.
- Kramer P. The CD95 (APO-l/Fas) receptor/ligand system death signals and diseases // Cell Death Differ. — 1996. — Vol. 3. — P. 159−60
- Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease // Am J Hypertens. 2001. — Vol. 14. — P. 44S-54S.
- Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease // J Interferon Cytokine Res. 1999. — Vol. 19. — P. 91−104.
- Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion // J Mol Histol. 2004. — Vol. 35. -P. 233−45.
- Kuhn H, Chan L. The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions // Curr Opin Lipidol. 1997. — Vol. 8. — P. 111−7.
- Kuhn H, Heydeck D, Hugou I, Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis // J Clin Invest. 1997. -Vol. 99.-P. 888−93.
- Laitinen К, Laurila A, Pyhala L, Leinonen M, and Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits // Infect Immun. 1997. — Vol. 65. — P. 4832−4835
- Lalli J, Harrer JM, Luo W, Kranias EG, Paul RJ. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle // Circ Res. 1997. — Vol. 80. — P. 506−13.
- Laukkanen J, Yla-Herttuala S. Genes involved in atherosclerosis // Exp Nephrol. 2002. — Vol. 10.-P. 150−63.
- Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, and Nicoletti A. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice // Circulation. -2001.-Vol. 104.-P. 197−202.
- Lazo PA, Cuevas L, Gutierrez del Arroyo A, Orue E. Ligation of CD53/OX44, a tetraspan antigen, induces homotypic adhesion mediated by specific cell-cell interactions // Cell Immunol. 1997. — Vol. 178. — P. 13 240.
- Leake DS, Peters TJ. Proteolytic degradation of low density lipoproteins by arterial smooth muscle cells: the role of individual cathepsins // Biochim Biophys Acta. 1981.-Vol. 664.-P. 108−16.
- Lee TS, Yen HC, Pan CC, and Chau LY. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice // Arterioscler Thromb Vase Biol. 1999. — Vol. 19. — P. 734−742.
- Lee-Rueckert M, Vikstedt R, Metso J, Ehnholm C, Kovanen PT, Jauhiainen M. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells // J Lipid Res. 2006. — Vol. 47. — P. 1725−32.
- Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma//Am J Pathol.- 1993. -Vol. 143.-P. 1551−9.
- Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines // J Clin Invest. 1995. — Vol. 95. — P. 122−33.
- Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? // FASEB J. -1999.-Vol. 13.-P. 1137−43.
- Li PF, Maasch C, Haller H, Dietz R, von Harsdorf R. Requirement for protein kinase С in reactive oxygen species-induced apoptosis of vascular smooth muscle cells // Circulation. 1999. — Vol. 100. — P. 967−973
- Li S, Sims S, Jiao Y, Chow LH, Pickering JG. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes // Circ Res. -1999.-Vol. 85.-P. 338−48
- Li SL, Valente AJ, Qiang M, Schlegel W, Gamez M, Clark RA. Multiple PU. l sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells // Blood. 2002. — Vol. 99. -P. 4578−4587.
- Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction // Science. 1992. — Vol. 257. — P. 967−71.
- Libby P. Inflammation in atherosclerosis // Nature. 2002. — Vol. 420. — P. 868−74.
- Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist//Blood. -2003. Vol. 102. — P. 2728−30.
- Lim DS, Roberts R, and Marian AJ. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes // J Am Coll Cardiol. 2001. — Vol. 38. — P. 1175−1180
- Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation // Circ Res. 1991. — Vol. 68.-P. 106−13.
- Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries // J Clin Invest.1990.-85.-P. 2004−8.
- Lindstedt KA and Kovanen PT. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture // Curr Opin Lipidol. 2004. — Vol. 15. — P. 567−573
- Lipke DW, Couchman JR. Increased proteoglycan synthesis by the cardiovascular system of coarctation hypertensive rats // J Cell Physiol.1991. Vol. 147.-P. 479−86
- Liuzzo G, Giubilato G, Pinnelli M. T cells and cytokines in atherogenesis // Lupus. 2005. — Vol. 14. — P. 732−5.
- Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays // Nat Biotechnol. 1996. — Vol. 14. — P. 1675−80.
- Lord RS and Bobryshev YV. Clustering of dendritic cells in athero-prone areas of the aorta // Atherosclerosis. 1999. — Vol. 146. — P. 197−198
- Lu H, Cassis LA, Daugherty A. Atherosclerosis and arterial blood pressure in mice // Curr Drug Targets. 2007. — Vol. 8. — P. 1181−1189.
- Lyall F, Morton JJ, Lever AF, Cragoe EJ. Angiotensin II activates Na H exchange and stimulates growth in vascular smooth muscle cells // J Hypertens Suppl. — 1988. — Vol. 6. — P. S43 8−41.
- Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease //N Engl J Med. -2005. -Vol. 353.-P. 1489−501.
- MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function // Annu Rev Immunol. 1997.-Vol. 15.-P. 323−350
- Majesky MW, Daemen MJ, Schwartz SM. Alpha 1 adrenergic stimulation of platelet — derived growth factor A — chain gene expression in rat aorta // J Biol Chem. — 1990.-Vol. 265.-P. 1082−8.
- Mallat Z and Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives // Curr Opin Lipidol. -2002.-Vol. 13.-P. 523−529.
- Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis // Circ Res. 1999a. -Vol. 85.-P. el7-e24.
- Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, and Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability // Circulation. 2001a. — Vol. 104. — P. 1598−1603.
- Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, et al. Inhibition of transforming growth factor beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice // Circ Res. 2001c.-Vol. 89.-P. 930−934.
- Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, and Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death //
- Arterioscler Thromb Vase Biol. 1999b. — Vol. 19. — P. 611−616.
- Marcus, S.L. and M.J. Modak. Observations on template-specific conditions for DNA synthesis by avian myeloblastosis virus DNA polymerase // Nucleic Acids Res. 1976. — Vol.3. — P. 1473−1486.
- Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence // Immunity. 2003. — Vol. 19. — P. 583−93.
- Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions // Proc Natl Acad Sci USA.- 1990. -Vol. 87.-P. 9133−7.
- Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, Henz B, et al. What is the physiological function of mast cells? // Exp Dermatol. -2003.-Vol. 12.-P. 886−910.
- McCaffrey TA. TGF-betas and TGF-beta receptors in atherosclerosis // Cytokine Growth Factor Rev. 2000. — Vol. 11. — P. 103−14.
- McCormick SM, Eskin SG, Mclntire LV, Teng CL, Lu CM, Russell CG, Chittur KK. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells // Proc Natl Acad Sci USA. -2001.-Vol. 98.-P. 8955−60.
- McEver RP, Moore KL, Cummings RD. Leulcocyte trafficking mediated by selectin-carbohydrate interactions // J Biol Chem. 1995. — Vol. 270. — P. 11 025−8.
- Melnick JL, Ни C., Burek J et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis // J Med Virol. 1994. — Vol. 42. — P. 170−174.
- Michelsen KS, Doherty TM, Shah PK, and Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis // J Immunol. -2004a. Vol. 173. — P. 5901−5907.
- Migeotte I, Riboldi E, Franssen JD, Gregoire F, Loison U, Wittamer V, et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2 // J Exp Med. 2005. — Vol. 201. — P. 83−93.
- Mii S, Ware JA, Kent КС. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration // Surgery. 1993. -Vol. 114.-P. 464−70.
- Mikita T, Porter G, Lawn RM, Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus // J Biol Chem. 2001. — Vol. 276. — P. 4 572 945 739.
- Miller YI, Chang MK, Binder CJ, Shaw PX, and Witztum JL. Oxidized low density lipoprotein and innate immune receptors // Curr Opin Lipidol. -2003a. Vol. 14. — P. 437−445.
- Millonig G, Malcom GT, and Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study // Atherosclerosis. 2002. — Vol. 160.-P. 441−448.
- Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, and Bhan AK.-Chronic intestinal inflammatory condition generates IL-10-producing regulatory В cell subset characterized by CD Id upregulation // Immunity. -2002.-Vol. 16.-P. 219−230.
- Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, and Kuo CC. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice // J Infect Dis. 1999. -Vol. 180.-P. 238−241.
- Moratz C, Kang VH, Druey KM, Shi CS, Scheschonka A, Murphy PM, Kozasa T, Kehrl JH. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of В lymphocytes // J Immunol. -2000.-Vol. 164.-P. 1829−38.
- Mosorin M, Surcel HM, Laurila A, Lehtinen M, Karttunen R, Juvonen J, et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery // Arterioscler Thromb Vase Biol. -2000. Vol. 20. — P. 1061−1067.
- Murakami M, Kudo I. New phospholipase A (2) isozymes with a potential role in atherosclerosis // Curr Opin Lipidol. 2003. — Vol. 14. — P. 431−6.
- Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium // J Control Release. 2001. — Vol. 71. — P. 1 -21.
- Naghavi M et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I // Circulation. 2003. -Vol. 108.-P. 1664−1672.
- Nahmod KA, Vermeulen ME et al. Control of dendritic cell differentiation by angiotensin II // Faseb J. 2003. — Vol. 17. — P. 491 -493.
- Nakahashi TK, Hoshina K, Tsao PS, Sho E, Sho M, ICarwowski JK, Yeh C, et al. Flow loading induces macrophage antioxidative gene expression in experimental aneurysms // Arterioscler Thromb Vase Biol. 2002. — Vol. 22.-P. 2017−22.
- Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, Watano K, et al. Natural killer T cells accelerate atherogenesis in mice // Blood. 2004. -Vol. 104.-P. 2051−2059.
- NakajimaT, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes // Circulation. 2002. — Vol. 105. — P. 570−5.
- Naora H. Involvement of ribosomal proteins in regulating cell growth and apoptosis: translational modulation or recruitment for extraribosomal activity? // Immunol Cell Biol. 1999. — Vol. 77. — P. 197−205.
- Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes // Circulation. 2002. — Vol. 106. — P. 2894−2900.
- Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques // J Clin Invest. -1991.-Vol. 88.-P. 1121−7.
- Newman PJ, Berndt MC, Gorski J, White GC 2nd, Lyman S, Paddock C, Muller WA. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily // Science. 1990. — Vol. 247. — P. 1219−22.
- Nhan TQ, Liles WC, Schwartz SM. Role of caspases in death and survival of the plaque macrophage // Arterioscler Thromb Vase Biol. 2005. — Vol. 25.-P. 895−903.
- Nicoletti A, Caligiuri G, Tornberg I, Kodama T, Stemme S, and Hansson GK. The macrophage scavenger receptor type A directs modified proteins to antigen presentation // Eur J Immunol. 1999. — Vol. 29. — P. 512−521.
- Nilsson J and Kovanen PT. Will autoantibodies help to determine severity and progression of atherosclerosis? // Curr Opin Lipidol. 2004. — Vol. 15. -P. 499−503.
- Norata GD, Pirillo A, Callegari E, Hamsten A, Catapano AL, Eriksson P. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL // Cardiovasc Res. -2003.-Vol. 59.-P. 169−80.
- O’Callaghan CJ, Williams B. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-beta (l) // Hypertension. 2000. — Vol. 36. — P. 319−24.
- Ocana E, P6rez-Requena J, Bohorquez JC, Brieva JA, Rodriguez C. Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: Role of CXCR4-CXCL12 in lymphoid recruitment // Atherosclerosis. 2008. — Vol. 200. — P. 264−70.
- Ohashi K, Burkart V, Flohe S, and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex // J Immunol. 2000. — Vol. 164.-P. 558−561.
- Ohki, R., K. Yamamoto, H. Mano, R.T. Lee, U. Ikeda, and K. Shimada. Identification of mechanically induced genes in human monocytic cells by DNA microarrays // J Hypertens. 2002. — Vol. 20. — P. 685−691.
- Ohura N, Yamamoto K, Ichioka S, Sokabe T, Nakatsuka H, Baba A, et al. Global analysis of shear stress-responsive genes in vascular endothelial cells //J Atheroscler Thromb.-2003.-Vol. 10.-P. 304−313.
- Okuda M, Nobutaka Inoue, Hiroshi Azumi, et al. Expression of Glutaredoxin in Human Coronary Arteries Its Potential Role in Antioxidant Protection Against Atherosclerosis // Arterioscler Thromb Vase Biol. -2001.-21.-P. 1483−1487.
- Olsen, M.H., K. Wachtell, K.L. Hermann, E. Frandsen, H. Dige-Petersen, J. et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? // Am Heart J. 2002. — Vol. 144. -P. 530−537.
- Ouhammouch, M. and E.N. Brody. Temperature-dependent template switching during in vitro cDNA synthesis by the AMV-reverse transcriptase // Nucleic Acids Res. 1992. — Vol. 20. — P. 5443−5450
- Owens GK, Schwartz SM, McCanna M. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats // Hypertension. -1988.-Vol. 11.-P. 198−207.
- Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats // Hypertension. 1987. — Vol. 9. — P. 178−87.
- Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehydemodified LDL reduces atherogenesis // Proc Natl Acad Sci USA.- 1995. Vol. 92. — P. 821−825.
- Palinski W., Rosenfeld ME., Yla-Herttuala S. et al. Low density lipoprotein undergoes oxidative modification in vivo // Proc Nat Acad Sci USA. 1989. -Vol. 86.-P. 1372−1376.
- Pampou SYu., Gnedoy SN, Bystrevskaya VB et al. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta // Virchows Arch. 2000. — V. 436. — P. 539−552.
- Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, et al. Novel candidate genes in unstable areas of human atherosclerotic plaques // Arterioscler Thromb Vase Biol. 2006. — Vol. 26. — P. 1837−44.
- Parker F. An electron microscopic study of experimental atherosclerosis // Amer J Pathol. 1960. — Vol. 36. — P. 19−53.
- Pedersen-Lane JH, Zurier RB, Lawrence DA. Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients // J Leukoc Biol. -2007.-Vol. 81.-P. 934−941.
- Peiser L, Mukhopadhyay S, and Gordon S. Scavenger receptors in innate immunity // Curr Opin Immunol. 2002. — Vol. 14. — P. 123−128.
- Pentikainen MO, Oorni K, Ala-Korpela M, Kovanen PT. Modified LDL -trigger of atherosclerosis and inflammation in the arterial intima // J Intern Med. 2000. — Vol. 247. — P. 359−70.
- Pillarisetti S, Рака L, Obunike JC, Berglund L, Goldberg IJ. Subendothelial retention of Iipoprotein (a) evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix // J Clin Invest. 1997. — Vol. 100.-P. 867−74.
- Pillarisetti S. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity // Trends Cardiovasc Med. -2000.-Vol. 10.-P. 60−5.
- Pinderski LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, and Fyfe AL Interleukin-10 blocks atherosclerotic events in vitro and invivo // Arterioscler Thromb Vase Biol. 1999. — Vol. 19. — P. 2847−2853.
- Pislaru- SV, Van RM, Pislaru C, Szelid Z, Theilmeier G, Ossewaarde JM, et al. Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs // Cardiovasc Res. 2003. — Vol. 57. — P. 834−842.
- Plante G.E. Vascular response to stress in health and disease // Metabolism. -2002.-Vol. 51.-P. 25−30.
- Pliyev BK. Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87) // Mbl Cell Biochem. 2009. — Vol. 321. — P. 111.-22.
- Pober JS, Cotran RS. Cytokines and endothelial cell biology // Physiol Rev. -1990.- Vol. 70.-P. 427−51.
- Pockley AG, De Faire U, Kiessling R, et al. Circulating heat shock protein and heat shock protein antibody levels in established hypertension // J Hypertens. 2002. — Vol. 20. — P. 1815−20.
- Pollman MJ, Naumovski L, Gibbons GH. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-betal in endothelial cells versus smooth muscle cells//Circulation.- 1999. Vol. 99. — P. 2019−26.
- Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. -Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II // Circ Res. 1996. — Vol. 79. — P. 748 -756.
- Prebeck S, Kirschning C, Durr S, Da CC, Donath B, Brand K, Redecke V, Wagner H, and Miethke T. Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation .of dendritic cells // J Immunol.-2001.-Vol. 167.-P. 3316−3323.
- Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis // Am J Med. 1999. — Vol. 107. — P. 85−97.
- Rabiet MJ, Huet E, Boulay F. The N-formyl peptide receptors and the. ' anaphylatoxin C5a receptors: an overview // Biochimie. — 2007. — Vol. 89: -P. 1089−1106.
- Rader DJ. Regulation of reverse cholesterol transport and clinical implications//Am J Cardiol. 2003.-Vol. 92. — P. 42J-49J.
- Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function // Adv Exp Med Biol. 1993. — Vol. 344. -P. 251−64.
- Raines EW and Ferri N. Thematic review series: The immune: system andatherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease // J Lipid Res. 2005. — Vol. 46. — P. 1081−1092.
- Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis // Br Heart J. 1993. — Vol. 69. — P. S30−7.
- Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, and Muller WA. Differentiation of monocytes into dendritic cells in a. model of transendothelial trafficking // Science. 1998. — Vol. 282. — P. 480−483.
- Ranzolin A, Bohn JM, Norman GL, Manenti E, Bodanese LC, von Muhlen CA, and Staub HL. Antibeta2-glycoprotein I antibodies as risk factors for acute myocardial infarction // Arq Bras Cardiol. 2004. — Vol. 83. — P. 141 144.
- Reape TJ, Rayner K, Manning CD, Gee AN, Barnette MS, Burnand KG, Groot PH. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques // Am J Pathol. 1999. -Vol. 154.-P. 365−74.
- Renier G, Clement I, Desfaits AC, Lambert A. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production // Endocrinology. 1996. — Vol. 137. — P. 4611−8.
- Riddle EL, Rau’l A. Schwartzman, Meredith Bond, Paul A. InselMuIti-Tasking RGS Proteins in the Heart. The Next Therapeutic Target? // Circ. Res. 2005. — Vol. 96. — P. 401−411.
- Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH.
- Platelet-derived growth factor is angiogenic in vivo // Growth Factors. -1992.-Vol. 7.-P. 261−6.
- Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, and Hansson GK. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis // J Clin Invest. 2003. — Vol. 112. — P. 1342−1350.
- Robertson AL, Hansson GK. T cells in atherogenesis. For better or for worse? // Arterioscler Thromb Vase Biol. 2006. — Vol. 26. — P. 2421−2432.
- Robertson J. The influence of mechanical factors on the structure of the peripheral arteries and the localization of atherosclerosis // J Clin Pathol. -1960.-Vol.13. P. 199−204.
- Rodriguez C, Raposo B, Martinez-Gonzalez J, Casani L, Badimon L. Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall // Arterioscler Thromb Vase Biol. 2002. — Vol. 22. -P. 1409−14.
- Ross R. Atherosclerosis an inflammatory disease // N Engl J Med. — 1999. -Vol. 340.-P. 115−126.
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s // Nature. 1993.-Vol. 362.-P. 801−9.
- Ross R., Glomset JA. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis // Science. 1973. — V.180. — P. 1332−1339.
- Roth, J., T. Vogl, C. Sorg and C. Sunderkotter. Phagocyte-specific SI00 proteins: a novel group of proinflammatory molecules // Trends Immunol. -2003. Vol. 24.-P. 155−158.
- Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease // Pharmacol Ther. 2002. — Vol. 94. — P. 123−35.
- Sainz J, Sata M. Open sesame! CXCR4 blockade recruits neutrophils into the plaque // Circ Res. 2008. — Vol. 102. — P. 154−6.
- Saouaf R, Takasaki I, Eastman E, Chobanian AV, Brecher P. Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension // J Clin Invest. 1991. — Vol. 88. — P. 1182−9.
- Sasamura H, Shimizu-Hirota R, Saruta T. Extracellular matrix remodeling in hypertension // Current Hypertension Reviews. 2005. — Vol. 1. — P. 5160.
- Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses // Nat Rev Immunol. 2002. -Vol. 2.-P. 965−75.
- Sawamura T, Kume N, Aoyama T, Moriwaki PI, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein // Nature. -1997. Vol. 386.-P. 73−7.
- Schecter AD, Berman AB, Taubman MB. Chemokine receptors in vascular smooth muscle // Microcirculation. 2003. — Vol. 10. — P. 265−72.
- Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray // Science. 1995. — Vol. 270. — P. 467−70.
- Schmitz G, Langmann T, Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism // J Lipid Res. 2001. — Vol. 42. — P. 1513−20.
- Schuppan D, Cantaluppi MC, Becker J, Veit A, Bunte T, Troyer D, et al. Undulin, an extracellular matrix glycoprotein associated with collagen fibrils // J Biol Chem. 1990. — Vol. 265. — P. 8823−32.
- Schwartz SM, deBlois D, O’Brien ER. The intima. Soil for atherosclerosis and restenosis // Circ Res. 1995. — Vol. 77. — P. 445−65.
- Schwencke C, Schmeisser A, Walter C, Wachter R, Pannach S, Week B, et al. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis // Cardiovasc Res. 2005. -Vol. 68.-P. 128−35.
- Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck ВТ, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epasl-/- mice // Nat Genet.2003.-Vol. 35.-P. 331−40.
- Seko Y, Sato O, Takagi A, Tada Y, Matsuo H, Yagita H, Okumura K, and Yazaki Y. Perforin-secreting killer cell infiltration in the aortic tissue of patients with atherosclerotic aortic aneurysm // Jpn Circ J. 1997. — Vol. 61.-P. 965−970.
- Sela S. et al. Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat // Hypertension.2004. Vol. 44. — P. 764−769.
- Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, et al. Gene expression phenotypes of atherosclerosis // Arterioscler Thromb Vase Biol. 2004. — Vol. 24. — P. 1922−1927.
- Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury // J Biol Chem. 2005. — Vol. 280. -P. 31 230−9.
- Shaulian E, Karin M. AP-1 as a regulator of cell life and death // Nat Cell Biol. 2002. — Vol. 4. — P. E131−6.
- Shaw, A., and Q. Xu. Biomechanical stress-induced signaling in smooth muscle cells: an update // Curr Vase Pharmacol. 2003. — Vol. 1. — P.41−58.
- Shiffman D, Mikita T, Tai JT, Wade DP, Porter JG, Seilhamer JJ, Somogyi R, Liang S, Lawn RM. Large scale gene expression analysis of cholesterol-loaded macrophages // J Biol Chem. 2000. — Vol. 275. — P. 37 324−32.
- Sidawy AN, Mitchell ME, Neville RF. Peptide growth factors and signal transduction//Semin Vase Surg. 1998.-Vol. 11.-P. 149−55.
- Siegbahn A, Hammacher A, Westermark B, Heldin CH. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes // J Clin Invest. 1990. — Vol. 85. -P. 916−20.
- Smedly, L.A., M.G. Tonnesen, R.A. Sandhaus, C. Haslett, L.A. Guthrie, R.B. Johnston, P.M. Henson, and G.S. Worthen. Neutrophil-mediated injury to endothelial cells // J Clin Invest. 1986. — Vol. 77. — P. 1233−1243.
- Sohma Y, Sasano H, Shiga R, Saeki S, Suzuki T, Nagura H, Nose M, and Yamamoto T. Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits // Proc Natl Acad Sci USA. -1995.-Vol. 92.-P. 4937−4941.
- Song D, Sakamoto S, Taniguchi T. Inhibition of poly (ADP-ribose) polymerase activity by Bcl-2 in association with the ribosomal protein S3a // Biochemistry. 2002. — Vol. 41. — P. 929−34.
- Spaet TH, Stemerman MB, Veith FJ, Lejnieks I. Intimal injury and regrowth in the rabbit aorta- medial smooth muscle cells as a source of neointima // Circ Res. 1975. — Vol. 36. — P. 58−70.
- Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta // J Cell Biol. 1987. — Vol. 105. — P. 1039−45.
- Springer ТА. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm//Cell. 1994.-Vol. 76.-P. 301−14.
- Stanton LW. Methods to profile gene expression // Trends Cardiovasc Med. -2001.-Vol. 11.-P. 49−54.
- Thromb Vase Biol. 1995.-Vol. 15.-P. 1512−1531.
- Stary HC, McMillan GC. Kinetics of cellular proliferation in experimental atherosclerosis. Radioautography with drain counts in cholesterol-fed rabbits//Arch Pathol. 1970.-Vol. 89.-P. 173−183.
- Steinberg D, Parthasarathy S, Carew ТЕ, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity // N Engl J Med. 1989. — Vol. 320. — P. 915−24.
- Steinberg D. At last, direct evidence that lipoxygenases play a role in atherogenesis//J Clin Invest. 1999.-Vol. 103.-P. 1487−8.
- Steinberg D. Lipoproteins and pathogenesis of atherosclerosis // Circulation. 1987. — Vol. 76. — P. 508−514.
- Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, and Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein // Proc Natl Acad Sci U S A. 1995. — Vol. 92. — P. 3893−3897.
- Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1 // Arterioscler Thromb. 1992. — Vol. 12. — P. 206−11.
- Stepien O, Zhang Y, Zhu D, Marche P. Dual mechanism of action of amlodipine in human vascular smooth muscle cells // J Hypertens. 2002. -Vol. 20.-P. 95−102.
- Storey JD, Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays // Methods Mol Biol. 2003. — Vol. 224.-P. 149−57.
- Stouffer GA, Owens GK. Angiotensin II induced mitogenesis of spontaneously hypertensive rat derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-b // Circ Res. — 1992. — Vol. 70. — P. 820−8.
- Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data // Bioinformatics. 2002. — Vol. 18. — P. 207−8.
- Sukhanov S, Hua Song Y, Delafontaine P. Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells // Biochem Biophys Res Commun. 2003. — Vol. 306. — P. 443−9.
- Sutcliffe MC, Davidson JM. Effect of static stretching on elastin production by porcine aortic smooth muscle cells // Matrix. 1990. — Vol. 10. — P. 14 853.
- Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection // Nature. 1997. — Vol. 386.-P. 292−296.
- Tabas I. Apoptosis and plaque destabilization: the role of macrophage apoptosis induced by cholesterol // Cell Death & Differentiation. 2004. -Vol. 11.-P. S12-S16.
- Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency // Arterioscler Thromb Vase Biol. 2005. — Vol. 25. — P. 22 552 264.
- Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals // Med Electron Microsc. 2002. — Vol. 35. — P. 179 203.
- Tall AR, Jiang X, Luo Y, Silver D.1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis // Arterioscler Thromb Vase Biol. 2000. — Vol. 20. — P. 1185−8.
- Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms // Hypertension. 2003. — Vol. 42. — P. 1075−81.
- Tarrant JM, Robb L, van Spriel AB, Wright MD. Tetraspanins: molecular organisers of the leukocyte surface // Trends Immunol. 2003. — Vol. 24. -P. 610−7.
- Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall // Circ Res.-2001.-Vol. 88.-P. 877−87.
- Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways // Physiol Rev. 2006. — Vol. 86.-P. 515−81.
- Terpstra V, van Amersfoort ES, van Velzen AG, Kuiper J, van Berkel TJ. Hepatic and extrahepatic scavenger receptors: function in relation to disease // Arterioscler Thromb Vase Biol. 2000. — Vol. 20. — P. 1860−72.
- Tertov V.V., Sobenin IA., Gabbasov ZA et al., Multiple-modified desialylated low density lipoproteins that cause intracellular lipidaccumulation. Isolation, fractionation and characterization // Lab Invest. -1992. Vol. 67. — P. 665−675.
- Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent // J Biol Chem. 1996. — Vol. 271. — P. 603−6.
- Thyberg J., Nilsson J., Palmberg L., Sjolund M. Adult human arterial smooth muscle cells in primary culture. Modulation from contractile to synthetic phenotype // Cell Tissue Res. 1985. — Vol. 239. — P. 69−74.
- Tobias P and Curtiss LK. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis // J Lipid Res. 2005. — Vol. 46. — P. 404−411.
- Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL // Cell. 1998. — Vol. 93. — P. 241−52.
- Tran PK, Agardh HE, Tran-Lundmark K, Ekstrand J, Roy J, Henderson B, et al. Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions // Atherosclerosis. 2007. — Vol. 190. — P. 264−70.
- Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta // Nature. 1988. — Vol. 334. — P. 260−2.
- Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, Hansson GK, and Berne GP. CD ld-dependent activation of NKT cells aggravates atherosclerosis // J Exp Med. 2004. — Vol. 199. — P. 417−422.
- Umehara, H., E.T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie, and T. Imai. Fractalkine in Vascular Biology // Arterioscler Thromb Vase Biol. 2004. -Vol. 24.-P. 34−40.
- Van Zwieten, P.A. The role of angiotensin II receptors and their antagonists in hypertension // Ann Ital Med Int. 2000. — Vol. 15. — P. 85−91.
- Vanderlaan PA and Reardon CA. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis // J Lipid Res. 2005. — Vol. 46. -P. 829−838.
- Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lai A, Wang CJ, et al. Analysis of human transcriptomes // Nat Genet. 1999. -Vol. 23.-P. 387−8.
- Vellaichamy E, Khurana ML, Fink J, Pandey KN. Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A // J Biol Chem. -2005. Vol. 280. — P. 19 230−42.
- Vemuganti R, Dempsey RJ. Increased expression of genes that control ionic homeostasis, second messenger signaling and metabolism in the carotid plaques from patients with symptomatic stroke // J Neurochem. 2006. -Vol. 97.-P. 92−6.
- Virgili F, Ambra R, Muratori F, Natella F, Majewicz J, Minihane AM, Rimbach G. Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells // Antioxid Redox Signal. -2003.-Vol. 5.-P. 237−47.
- Wabnitz GH, Kocher T, Lohneis P, Stober C, Konstandin MH, Funk B, et al. Costimulation induced phosphorylation of L plastin facilitates surface transport of the T cell activation molecules CD69 and CD25 // Eur J Immunol. 2007. — Vol. 37. — P. 649−662.
- Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism // J Lipid Res. 2002. -Vol. 43.-P. 177−86.
- Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH,
- Funa К. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease // Am J Pathol. 1993a. — Vol. 142.-P. 71−8.
- Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin CH, Funa K. Induction of transforming growth factor-beta during cardiac allograft rejection//J Immunol. 1993b.-Vol. 151.-P. 1147−57.
- Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases // Circulation. 1997. — Vol. 96. — P. 4083−94.
- Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, Lysko PG. Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions // FEBS Lett. 1999. — Vol. 462. — P. 145−50.
- Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response // J Biol Chem. 1996. -Vol. 271. -P. 24 286−93.
- Wang XQ, Panousis CG, Alfaro ML, Evans GF, Zuckerman SH. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Statl pathway // Arterioscler Thromb Vase Biol. -2002.-Vol. 22.-P. e5−9.
- Ward C, Dransfield I, Chilvers ER, Haslett C, Rossi AG. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets // Trends Pharmacol Sci. 1999. — Vol. 20. — P. 503−9.
- Ward Y, Kelly K. Gem protein signaling and regulation // Methods Enzymol. 2006. — Vol. 407. — P. 468−83.
- Weis M, Schlichting CL, Engleman EG, and Cooke JP. Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases // Arterioscler Thromb Vase Biol. 2002. — Vol. 22. — P. 1817−1823.
- Whitman SC, Ravisankar P, and Daugherty A. IFNgamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice // J Interferon Cytokine Res. 2002a. — Vol. 22. — P. 661−670.
- Whitman SC, Ravisankar P, and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma // Circ Res. 2002b. — Vol. 90. — P. E34-E38.
- Whitman SC, Ravisankar P, Elam H, and Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice // Am J Pathol.-2000.-Vol. 157.-P. 1819−1824.
- Wick G, Romen M, Amberger A, Metzler В, Mayr M, Falkensammer G, and Xu Q. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue // FASEB J. 1997. — Vol. 11. — P. 1199−1207.
- Williams B. The year in hypertension // J Am Coll Cardiol. 2006. — Vol. 48.-P. 1698−711.
- Williams KJ. Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis // Curr Opin Lipidol. 2001. — Vol. 12. — P. 477−87.
- Wissler RW. The arterial medial cell, smooth muscle or multifunctional mesenchyme // J Atheroscler Res. 1968. — Vol.8. — P. 201−213.
- Wissler RW., Moskowitz M., Hunghes R., Petrie L. A study of the gistogenesis of atherosclerosis in man // Circulation. 1958. — Vol.18. — P. 497−503.
- Wlodarski P, Zhang Q, Liu X, Kasprzycka M, Marzec M, Wasik MA. PU. l activates transcription of SHP-1 gene in hematopoietic cells // J Biol Chem. -2007.-Vol. 282.-P. 6316−23.
- Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis // Science. 1995. -Vol. 270.-P. 1326−31.
- Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages // J Immunol. 1994. -Vol. 152.-P. 3637−44.
- Xu C, Zarins CK, Bassiouny HS, Briggs WH, Reardon C, Glagov S. Differential transmural distribution of gene expression for collagen types I and III proximal to aortic coarctation in the rabbit // J Vase Res. 2000. -Vol. 37.-P. 170−82.
- Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufmann SH, and Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65 // Arterioscler Thromb. 1992.-Vol. 12.-P. 789−799.
- Xu Q. Role of heat shock proteins in atherosclerosis // Arterioscler Thromb Vase Biol. 2002. — Vol. 22. — P. 1547−1559.
- Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, et al. Tolllike receptor-4 is expressed by macrophages in murine and human lipidrich atherosclerotic plaques and upregulated by oxidized LDL II Circulation. -2001.-Vol. 104.-P. 3103−3108.
- Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death // Proc Natl Acad Sci USA.- 1996. Vol. 93. — P. 156−160.
- Yamada Y, Doi T, Hamakubo T, Kodama T. Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the centralnervous system // Cell Mol Life Sci. 1998. — Vol. 54. -P. 628−40.
- Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays // Circulation. 2000. — Vol. 102. — P. 3046−3052.
- Yap AS, Kovacs EM. Direct cadherin-activated cell signaling: a view from the plasma membrane // J Cell Biol. 2003. — Vol. 160. — P. 11−6.
- Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques // Atherosclerosis. 2004. — Vol. 176. — P. 101−110.
- Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, and Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL // Arterioscler Thromb. 1994. — Vol. 14.-P. 32−40.
- Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew ТЕ, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man // J Clin Invest. -1989.-Vol. 84.-P. 1086−95.
- Yla-Herttuala S, Salonen JT. Role of lipid oxidation in the development of atherosclerosis // Duodecim. 1994. — Vol. 110. — P. 1643−52.
- Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Regression of atherosclerosis by amlodipine via antiinflammatory and anti-oxidative stress actions // Hypertens Res. 2006. -Vol. 29.-P. 457−466.
- Yunta M, Lazo PA. Apoptosis protection and survival signal by the CD53 tetraspanin antigen // Oncogene. 2003a. — Vol. 22. — P. 1219−1224.
- Yunta M, Lazo PA. Tetraspanin proteins as organisers of membrane microdomains and signalling complexes // Cell Signal. 2003. — Vol. 15. -P. 559−64.
- Yunta M, Rodri’guez-Barbero A, Arevalo MA, Lopez-Novoa JM, Lazo PA. Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primary cultures of mesangial cells // Kidney Int. 2003b. — Vol. 63. — P. 534−542.
- Zargham R, Thibault G. Alpha 8 integrin expression is required for maintenance of the smooth muscle cell differentiated phenotype //
- Cardiovasc Res.-2006.-Vol. 71.-P. 170−8.
- Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis // Circ Res. 2008b. — Vol. 102. -P. 209−17.
- Zernecke A, Shagdarsuren E, Weber C. Chemokines in Atherosclerosis. An Update // Arterioscler Thromb Vase Biol. 2008a. — Vol. 28. — P. 1897−908.
- Zhou D, Yang PY, Zhou B, Rui YC. Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis // Clin Exp Pharmacol Physiol. 2007. -Vol. 34. -P. 185−90.
- Zhou X and Hansson GK. Detection of В cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice // Scand J Immunol. 1999. — Vol. 50. — P. 25−30.
- Zhu W, Roma P, Pellegatta F, and Catapano AL. Oxidized-LDL induce the expression of heat shock protein 70 in human endothelial cells // Biochem Biophys Res Commun. 1994. — Vol. 200. — P. 389−394.
- Zhu WM, Roma P, Pirillo A, Pellegatta F, and Catapano AL. Oxidized LDL induce hsp70 expression in human smooth muscle cells // FEBS Lett. -1995.-Vol. 372. P. 1−5.
- Zurgil N, Afrimzon E, Shafran Y, Shovman O, Gilburd B, Brikman H, Shoenfeld Y, Deutsch M. Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis // Atherosclerosis. 2007. — Vol. 190. — P. 73−83.